ID   MX2_RAT                 Reviewed;         659 AA.
AC   P18589;
DT   01-NOV-1990, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1990, sequence version 1.
DT   29-MAY-2024, entry version 133.
DE   RecName: Full=Interferon-induced GTP-binding protein Mx2;
DE   AltName: Full=Myxovirus resistance protein 2;
GN   Name=Mx2;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBCELLULAR LOCATION, AND INDUCTION.
RX   PubMed=2173790; DOI=10.1128/jvi.64.12.6263-6269.1990;
RA   Meier E., Kunz G., Haller O., Arnheiter H.;
RT   "Activity of rat Mx proteins against a rhabdovirus.";
RL   J. Virol. 64:6263-6269(1990).
RN   [2]
RP   REVIEW, AND INDUCTION.
RX   PubMed=18062906; DOI=10.1016/j.micinf.2007.09.010;
RA   Haller O., Stertz S., Kochs G.;
RT   "The Mx GTPase family of interferon-induced antiviral proteins.";
RL   Microbes Infect. 9:1636-1643(2007).
CC   -!- FUNCTION: Interferon-induced dynamin-like GTPase with antiviral
CC       activity against vesicular stomatitis virus (VSV).
CC       {ECO:0000269|PubMed:2173790}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:2173790}.
CC   -!- INDUCTION: By type I and type III interferons.
CC       {ECO:0000269|PubMed:18062906, ECO:0000269|PubMed:2173790}.
CC   -!- SIMILARITY: Belongs to the TRAFAC class dynamin-like GTPase
CC       superfamily. Dynamin/Fzo/YdjA family. {ECO:0000255|PROSITE-
CC       ProRule:PRU01055}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X52712; CAA36936.1; -; mRNA.
DR   PIR; S11736; S11736.
DR   AlphaFoldDB; P18589; -.
DR   SMR; P18589; -.
DR   PhosphoSitePlus; P18589; -.
DR   AGR; RGD:628821; -.
DR   RGD; 628821; Mx2.
DR   InParanoid; P18589; -.
DR   Reactome; R-RNO-1169408; ISG15 antiviral mechanism.
DR   PRO; PR:P18589; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; IBA:GO_Central.
DR   GO; GO:0005874; C:microtubule; IBA:GO_Central.
DR   GO; GO:0005643; C:nuclear pore; ISO:RGD.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0005525; F:GTP binding; ISO:RGD.
DR   GO; GO:0003924; F:GTPase activity; IBA:GO_Central.
DR   GO; GO:0008017; F:microtubule binding; IBA:GO_Central.
DR   GO; GO:0051607; P:defense response to virus; ISO:RGD.
DR   GO; GO:0045087; P:innate immune response; IEA:UniProtKB-KW.
DR   GO; GO:0051726; P:regulation of cell cycle; ISO:RGD.
DR   GO; GO:0046822; P:regulation of nucleocytoplasmic transport; ISO:RGD.
DR   GO; GO:0035455; P:response to interferon-alpha; ISO:RGD.
DR   GO; GO:0009615; P:response to virus; IDA:UniProtKB.
DR   CDD; cd08771; DLP_1; 1.
DR   Gene3D; 1.20.120.1240; Dynamin, middle domain; 1.
DR   Gene3D; 3.40.50.300; P-loop containing nucleotide triphosphate hydrolases; 1.
DR   InterPro; IPR022812; Dynamin.
DR   InterPro; IPR001401; Dynamin_GTPase.
DR   InterPro; IPR019762; Dynamin_GTPase_CS.
DR   InterPro; IPR045063; Dynamin_N.
DR   InterPro; IPR000375; Dynamin_stalk.
DR   InterPro; IPR030381; G_DYNAMIN_dom.
DR   InterPro; IPR003130; GED.
DR   InterPro; IPR020850; GED_dom.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   PANTHER; PTHR11566; DYNAMIN; 1.
DR   PANTHER; PTHR11566:SF217; INTERFERON-INDUCED GTP-BINDING PROTEIN MX1; 1.
DR   Pfam; PF01031; Dynamin_M; 1.
DR   Pfam; PF00350; Dynamin_N; 1.
DR   Pfam; PF02212; GED; 1.
DR   PRINTS; PR00195; DYNAMIN.
DR   SMART; SM00053; DYNc; 1.
DR   SMART; SM00302; GED; 1.
DR   SUPFAM; SSF52540; P-loop containing nucleoside triphosphate hydrolases; 1.
DR   PROSITE; PS00410; G_DYNAMIN_1; 1.
DR   PROSITE; PS51718; G_DYNAMIN_2; 1.
DR   PROSITE; PS51388; GED; 1.
PE   2: Evidence at transcript level;
KW   Antiviral defense; Cytoplasm; GTP-binding; Immunity; Innate immunity;
KW   Nucleotide-binding; Reference proteome.
FT   CHAIN           1..659
FT                   /note="Interferon-induced GTP-binding protein Mx2"
FT                   /id="PRO_0000206600"
FT   DOMAIN          65..338
FT                   /note="Dynamin-type G"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01055"
FT   DOMAIN          571..659
FT                   /note="GED"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00720"
FT   REGION          75..82
FT                   /note="G1 motif"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01055"
FT   REGION          100..102
FT                   /note="G2 motif"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01055"
FT   REGION          176..179
FT                   /note="G3 motif"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01055"
FT   REGION          245..248
FT                   /note="G4 motif"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01055"
FT   REGION          277..280
FT                   /note="G5 motif"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01055"
FT   REGION          547..567
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         75..82
FT                   /ligand="GTP"
FT                   /ligand_id="ChEBI:CHEBI:37565"
FT                   /evidence="ECO:0000255"
FT   BINDING         176..180
FT                   /ligand="GTP"
FT                   /ligand_id="ChEBI:CHEBI:37565"
FT                   /evidence="ECO:0000255"
FT   BINDING         245..248
FT                   /ligand="GTP"
FT                   /ligand_id="ChEBI:CHEBI:37565"
FT                   /evidence="ECO:0000255"
SQ   SEQUENCE   659 AA;  75074 MW;  14F916C5F4117E12 CRC64;
     MVLSTEENRS VDLVNLPSVP LPDGEAGVGE NNKDSLNNLC SQYEEKVRPC IDLIDSLRAL
     GVEQDLALPA IAVIGDQSSG KSSVLEALSG VALPRGSGIV TRCPLVLKLK KLNQGEEWKG
     KVTYDDIEVE LSDPSEVEEA INTGQNHIAG VGLGISDKLI SLDVSSPHVP DLTLIDLPGI
     TRVAVGNQPA DIGRQIKRLI TNYIQKQETI NLVVVPSNVD IATTEALSMA QKVDPDGDRT
     IGILTKPDLV DRGTEDKVVD VVRNLVCHLK KGYMIVKCRG QQDIQEQLSL AEALQKEQVF
     FKEHPQFRAL LEDGKATVPC LAERLTMELI SHICKSLPLL ENQIKESHQS TSEELQKYGA
     DIPEDENEKT LFLIEKINAF NQDITAIVEG EEIVREKECR LFTKLRKEFF LWSEEIERNF
     QKGSDALYKE VYTFEMQYRG RELPGFVNYK TFENIIRRQI KTLEEPAMEM LHKVTEIVRA
     AFTTVSEKNF SEFFNLHRTT KSKLEDIRLE QETEAEKSIR LHFQMEQIIY CQDQIYRKAL
     QKVREEEAEE EERKHGKSRS SQSKNLQTSS MDEIFQHLNA YRQEAHNRIS SHIPLIIQYF
     ILKMFAEKLQ KGMLQLLQDK DSCSWLLKEH SDTSEKRRFL KERLARLAQA QRRLAKFPG
//
